NO20041060L - Krystaller av hydroksynorefedrinderivat - Google Patents

Krystaller av hydroksynorefedrinderivat

Info

Publication number
NO20041060L
NO20041060L NO20041060A NO20041060A NO20041060L NO 20041060 L NO20041060 L NO 20041060L NO 20041060 A NO20041060 A NO 20041060A NO 20041060 A NO20041060 A NO 20041060A NO 20041060 L NO20041060 L NO 20041060L
Authority
NO
Norway
Prior art keywords
hydroxynorphedrine
crystals
derivative
methylethylüaminoüethylü
dimethylphenoxyüacetate
Prior art date
Application number
NO20041060A
Other languages
English (en)
Other versions
NO328252B1 (no
Inventor
Junichi Sonehara
Satoshi Akahane
Yukihiko Hotei
Hidetoshi Lsawa
Kiyoshi Kasai
Original Assignee
Kissei Pharmaceutical Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical Company filed Critical Kissei Pharmaceutical Company
Publication of NO20041060L publication Critical patent/NO20041060L/no
Publication of NO328252B1 publication Critical patent/NO328252B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO20041060A 2001-09-13 2004-03-12 Krystaller av hydroksynorefedrinderivat NO328252B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001277345 2001-09-13
PCT/JP2002/008596 WO2003024916A1 (en) 2001-09-13 2002-08-27 Crystals of hydroxynorephedrine derivative

Publications (2)

Publication Number Publication Date
NO20041060L true NO20041060L (no) 2004-06-11
NO328252B1 NO328252B1 (no) 2010-01-18

Family

ID=19101883

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20041060A NO328252B1 (no) 2001-09-13 2004-03-12 Krystaller av hydroksynorefedrinderivat

Country Status (28)

Country Link
US (1) US7208520B2 (no)
EP (1) EP1426355B1 (no)
JP (1) JP4157036B2 (no)
KR (2) KR100874952B1 (no)
CN (1) CN1275936C (no)
AT (1) ATE411276T1 (no)
AU (1) AU2002330453B2 (no)
BR (1) BR0212494A (no)
CA (1) CA2458544C (no)
CO (1) CO5560555A2 (no)
CY (1) CY1109409T1 (no)
DE (1) DE60229404D1 (no)
DK (1) DK1426355T3 (no)
EA (1) EA006022B1 (no)
EC (1) ECSP045017A (no)
ES (1) ES2314092T3 (no)
HR (1) HRP20040250A2 (no)
HU (1) HUP0401694A3 (no)
IL (2) IL160681A0 (no)
MX (1) MXPA04002449A (no)
NO (1) NO328252B1 (no)
NZ (1) NZ531602A (no)
PL (1) PL206246B1 (no)
PT (1) PT1426355E (no)
SI (1) SI1426355T1 (no)
UA (1) UA77000C2 (no)
WO (1) WO2003024916A1 (no)
ZA (1) ZA200401757B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
ES2309513T3 (es) * 2003-05-05 2008-12-16 Kissei Pharmaceutical Co., Ltd. Uso de derivados de acido fenoxiacetico para tratar vejiga hiperactiva.
DE10351271A1 (de) * 2003-10-31 2005-06-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Zusammensetzung zur Behandlung der Stressinkontinenz und/oder Mischinkontinenz
WO2005042021A2 (de) * 2003-11-03 2005-05-12 Boehringer Ingelheim International Gmbh Pharmazeutische zusammensetzung enthaltend einen beta-3-adrenozeptor-agonisten und einen alpha antagonisten und/oder einen 5-alpha reduktase-hemmer
DE10352132A1 (de) * 2003-11-04 2005-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Zusammensetzung aus einem Beta-3-Adrenozeptor-Agonisten und einem Alpha Agonisten
JP4808613B2 (ja) * 2004-03-24 2011-11-02 キッセイ薬品工業株式会社 頻尿または尿失禁の予防または治療用医薬
WO2005092321A1 (ja) * 2004-03-24 2005-10-06 Kissei Pharmaceutical Co., Ltd. 頻尿または尿失禁の予防または治療用医薬組成物
DK1612203T3 (da) * 2004-06-28 2007-12-03 Gruenenthal Gmbh Krystallinske former af (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenolhydrochlorid
CA2580170A1 (en) * 2004-10-18 2006-04-27 Boehringer Ingelheim International Gmbh Use of a beta-3 agonist for treating complaints of the prostate and the lower urogenital tract
DE102004050952A1 (de) * 2004-10-18 2006-04-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Zusammensetzung zur Behandlung von Beschwerden, die mit krankhaften Veränderungen oder Irritationen der Prostata verbunden sind
EP1809591A1 (en) 2004-10-26 2007-07-25 Kissei Pharmaceutical Co., Ltd. Synthesis of phenoxyacetic acid derivatives
TWI356699B (en) * 2004-11-10 2012-01-21 Kissei Pharmaceutical Agent for treating interstitial cystitis and agent
US8003694B2 (en) 2005-04-26 2011-08-23 Kissei Pharmaceutical Co., Ltd. Crystal of hydroxynorephedrin derivative hydrochloride ¼ hydrate
EP1878719A4 (en) * 2005-04-26 2010-10-06 Kissei Pharmaceutical HYDROXYNOREPHEDRINE DERIVATIVE HYDROCHLORIDE POLYMORPH CRYSTAL
EP1769792A1 (de) 2005-09-30 2007-04-04 Boehringer Ingelheim Pharma GmbH & Co.KG Verwendung eines beta-3-Adrenozeptor-Agonisten zur Behandlung von Nieren- und Blasenbeschwerden
KR20140143461A (ko) 2007-08-06 2014-12-16 알레간 인코포레이티드 데스모프레신 약물 전달을 위한 방법 및 장치
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
SI2712622T1 (sl) 2008-05-21 2016-10-28 Ferring B.V. Orodisperzibilni dezmopresin za povečanje začetnega obdobja spanja nemotenega z nokturijo
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY126489A (en) 1998-07-08 2006-10-31 Kissei Pharmaceutical Phenoxyacetic acid derivatives and medicinal compositions containing the same
JP4005731B2 (ja) * 1999-01-21 2007-11-14 キッセイ薬品工業株式会社 アミノエチルフェノキシ酢酸誘導体の結晶多形
JP4005729B2 (ja) * 1999-01-21 2007-11-14 キッセイ薬品工業株式会社 アミノエチルフェノキシ酢酸誘導体二水和物の結晶多形
JP4005730B2 (ja) * 1999-01-21 2007-11-14 キッセイ薬品工業株式会社 アミノエチルフェノキシ酢酸誘導体二水和物の結晶多形

Also Published As

Publication number Publication date
EP1426355A4 (en) 2006-03-29
KR20080098691A (ko) 2008-11-11
HUP0401694A2 (hu) 2004-11-29
MXPA04002449A (es) 2004-07-23
ECSP045017A (es) 2004-09-27
HUP0401694A3 (en) 2008-03-28
CA2458544C (en) 2010-08-17
KR20040044881A (ko) 2004-05-31
CN1553890A (zh) 2004-12-08
SI1426355T1 (sl) 2009-02-28
IL160681A0 (en) 2004-08-31
DK1426355T3 (da) 2009-02-23
HRP20040250A2 (en) 2005-02-28
US20040242686A1 (en) 2004-12-02
PL367874A1 (en) 2005-03-07
CY1109409T1 (el) 2014-07-02
ATE411276T1 (de) 2008-10-15
ZA200401757B (en) 2005-03-03
EA200400311A1 (ru) 2004-08-26
EP1426355A1 (en) 2004-06-09
JP4157036B2 (ja) 2008-09-24
US7208520B2 (en) 2007-04-24
PL206246B1 (pl) 2010-07-30
CN1275936C (zh) 2006-09-20
CA2458544A1 (en) 2003-03-27
AU2002330453B2 (en) 2008-04-17
EA006022B1 (ru) 2005-08-25
HK1070051A1 (en) 2005-06-10
WO2003024916A1 (en) 2003-03-27
DE60229404D1 (de) 2008-11-27
ES2314092T3 (es) 2009-03-16
PT1426355E (pt) 2008-11-03
EP1426355B1 (en) 2008-10-15
NO328252B1 (no) 2010-01-18
CO5560555A2 (es) 2005-09-30
BR0212494A (pt) 2004-08-24
KR100874952B1 (ko) 2008-12-19
UA77000C2 (en) 2006-10-16
JPWO2003024916A1 (ja) 2004-12-24
IL160681A (en) 2010-06-16
NZ531602A (en) 2006-01-27

Similar Documents

Publication Publication Date Title
DK1426355T3 (da) Krystaller af hydroxynorephedrinderivater
DE60034240D1 (de) Drogen zur behandlung maligner tumoren
MXPA04002167A (es) Inhibidores de la 17 beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades androgeno-dependientes.
EA200601269A1 (ru) Лекарственное средство, содержащее производные фенилпиперазина
NO20051209L (no) Pyrazolderivater, medisinske sammensetninger inneholdende slike, medisinsk anvendelse derav samt intermediater for samme
PT1259489E (pt) Compostos azapoliciclicos condensados con arilo.
NO20020968L (no) Glukopyranosyloksypyrazolderivater, medisinske sammensetninger inneholdende det samme og intermediater forfremstillingen derav
MY148480A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
BR0206955A (pt) Ligantes de receptores de canabinóides
SE0201544D0 (sv) Novel compounds and thier use
PT812588E (pt) Composicao farmaceutica externa para administracao topica contendo 2-amino-2-(2-(4-octilfenil)-etil)-propano-1,3-diol para o tratamento de doencas provocadas por uma afeccao imunitaria
DK2017276T3 (da) Phenylcarboxamid-forbindelser til behandling af smerte
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
NO304113B1 (no) Krystallinsk tiagabinhydrokloridmonohydrat, farmas°ytisk preparat som omfatter det, og anvendelse derav for fremstilling av et medikament
WO2004041802A8 (en) 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
IS6087A (is) N-(2-fenýl-4-amínó-bútýl)-1-naftamíð sem virka á móti taugakínín-1 viðtaka
NO20052699L (no) 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser.
WO2000056315A8 (en) Treatment of pain
IL177626A0 (en) Pharmaceutical compositions for treating sleep apnoea
PL370379A1 (pl) N-Tlenek prukaloprydu, sposób jego wytwarzania i zastosowanie oraz zawierająca go kompozycja i sposób jej wytwarzania
BRPI0513549A (pt) composições farmacêuticas para o tratamento de leishmaniose
BR0207307A (pt) Inibidores de glyt-1
BR0116724A (pt) Composto, método de tratamento de um distúrbio neurológico ou de uma doença neurodegenerativa, método de tratamento de dor, composição farmacêutica, uso de um composto, e, processos para a preparação e para a sìntese de um composto
ITTO20040343A1 (it) Uso di neboglamine (cr2249) come neuropsicotico e neuroprotettivo
UA84544C2 (ru) Замещенные фенилсульфонамидные ингибиторы продукции бета-амилоида

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees